Sofiva Genomics ,Ltd. Receivables

The latest receivables for 6615.TWO is $78M as of June 2026. That compares with $68M in the prior-year period — up 14.8% year over year. Investors often review this figure alongside Sofiva Genomics ,Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6615.TWO's receivables moved from $68M to $78M — a 14.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sofiva Genomics ,Ltd.'s operating scale or balance-sheet position.

A receivables figure of $78M for 6615.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6615.TWO's receivables ($78M), review year-over-year change from $68M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.